AMETEK, Inc. (AME) VP William Joseph Burke Sells 15,600 Shares
AMETEK, Inc. (NYSE:AME) VP William Joseph Burke sold 15,600 shares of the business’s stock in a transaction on Tuesday, September 11th. The shares were sold at an average price of $80.00, for a total transaction of $1,248,000.00. Following the sale, the vice president now owns 68,289 shares of the company’s stock, valued at approximately $5,463,120. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Shares of NYSE AME traded up $0.25 during trading on Wednesday, hitting $79.74. The stock had a trading volume of 1,127,300 shares, compared to its average volume of 1,217,817. AMETEK, Inc. has a 12 month low of $64.56 and a 12 month high of $80.21. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.71 and a quick ratio of 1.19. The firm has a market cap of $18.11 billion, a price-to-earnings ratio of 30.43, a PEG ratio of 2.22 and a beta of 1.21.
AMETEK (NYSE:AME) last posted its earnings results on Tuesday, July 31st. The technology company reported $0.83 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.78 by $0.05. AMETEK had a net margin of 16.65% and a return on equity of 16.94%. The firm had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.19 billion. During the same quarter in the prior year, the business posted $0.65 EPS. The business’s revenue was up 13.6% compared to the same quarter last year. research analysts anticipate that AMETEK, Inc. will post 3.21 EPS for the current fiscal year.
A number of analysts have commented on the stock. Cowen restated a “buy” rating and set a $85.00 price target on shares of AMETEK in a research note on Sunday, August 12th. ValuEngine upgraded shares of AMETEK from a “hold” rating to a “buy” rating in a research note on Thursday, August 2nd. Oppenheimer upped their target price on shares of AMETEK from $85.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 1st. Bank of America upped their target price on shares of AMETEK from $87.00 to $91.00 and gave the stock a “buy” rating in a research note on Wednesday, August 1st. Finally, BMO Capital Markets upped their target price on shares of AMETEK from $92.00 to $93.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 1st. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. AMETEK currently has a consensus rating of “Buy” and a consensus target price of $86.08.
A number of institutional investors and hedge funds have recently bought and sold shares of AME. BlackRock Inc. grew its position in AMETEK by 11.8% during the second quarter. BlackRock Inc. now owns 18,178,345 shares of the technology company’s stock valued at $1,311,749,000 after buying an additional 1,922,878 shares during the period. Millennium Management LLC grew its position in AMETEK by 169.1% during the second quarter. Millennium Management LLC now owns 1,647,306 shares of the technology company’s stock valued at $118,870,000 after buying an additional 1,035,084 shares during the period. The Manufacturers Life Insurance Company grew its position in AMETEK by 163.7% during the first quarter. The Manufacturers Life Insurance Company now owns 1,093,946 shares of the technology company’s stock valued at $83,106,000 after buying an additional 679,049 shares during the period. Renaissance Technologies LLC bought a new position in AMETEK during the second quarter valued at about $40,825,000. Finally, BNP Paribas Arbitrage SA grew its position in AMETEK by 714.2% during the second quarter. BNP Paribas Arbitrage SA now owns 610,418 shares of the technology company’s stock valued at $44,048,000 after buying an additional 535,447 shares during the period. Institutional investors own 85.12% of the company’s stock.
AMETEK Company Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. Its Electronic Instruments Group segment offers advanced instruments for the process, power and industrial, and aerospace markets; process and analytical instruments for the oil, gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage markets; and instruments for the laboratory equipment, ultraprecision manufacturing, medical, and test and measurement markets.
Recommended Story: Penny Stocks
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.